30-day FRN

66548

Federal Register / Vol. 80, No. 209 / Thursday, October 29, 2015 / Notices
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)

inspected or x-rayed as they enter the NIH
campus. For more information about the
security measures at NIH, please visit
http://www.nih.gov/about/
visitorsecurity.htm.

Dated: October 23, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.

Dated: October 22, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.

[FR Doc. 2015–27583 Filed 10–28–15; 8:45 am]

[FR Doc. 2015–27627 Filed 10–28–15; 8:45 am]

BILLING CODE 4140–01–P

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings

asabaliauskas on DSK5VPTVN1PROD with NOTICES

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Neural
injury and Neurodegeneration.
Date: November 12, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, [email protected].
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Application
Re-Review: Neurobiology of the Cochlear.
Date: November 18, 2015.
Time: 2:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Wei-Qin Zhao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5181
MSC 7846, Bethesda, MD 20892–7846, 301–
435–1236, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,

VerDate Sep<11>2014

23:37 Oct 28, 2015

Jkt 238001

Submission for OMB Review; 30-Day
Comment Request; A Multi-Center
International Hospital-Based CaseControl Study of Lymphoma in Asia
(AsiaLymph) (NCI)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute (NCI), the National
Institutes of Health, has submitted to the
Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on August 28,
2015, page number 52325 and allowed
60-days for public comment. One public
comment was received. The purpose of
this notice is to allow an additional 30
days for public comment. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
DATES: Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, or request more
information on the proposed project,
contact: Nathaniel Rothman, Senior
Investigator, Division of Cancer
Epidemiology and Genetics, 9609
Medical Center Drive MSC 9776 Room
SUMMARY:

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

6E134, Rockville, MD 20850 or call nontoll-free number (240) 276–7169 or
Email your request, including your
address to: [email protected].
Proposed Collection: A Multi-Center
International Hospital-Based CaseControl Study of Lymphoma in Asia
(AsiaLymph) (NCI), 0925–0654,
Expiration Date 10/31/2015—
REVISION, National Institutes of Health
(NIH).
Need and Use of Information
Collection: Incidence rates of certain
lymphomas have increased in the
United States and in many other parts
of the world. The contribution of
environmental, occupational, and
genetic factors to the cause of
lymphoma and leukemia has generated
a series of novel findings from
epidemiological studies conducted in
the United States that have attempted to
explain this increase. However, none of
the chemical associations have been
conclusively established and the
identification of the key, functional
alleles in gene regions associated with
risk of lymphoma requires further
elucidation. Further, the ability to
follow-up, confirm, and extend these
observations in the United States is
limited by the low prevalence and
limited range of several important
chemical and viral exposures and the
high to complete linkage disequilibrium
among key candidate genetic loci in
Western populations. To optimize the
ability to build on and clarify these
findings, it is necessary to investigate
populations that differ from those in the
West in both exposure patterns and
underlying genetic structure. A
multidisciplinary case-control study of
lymphoma in Asia, where lymphoma
rates have also risen, provides an
opportunity to replicate and extend
recent and novel observations made in
studies in the West in a population that
is distinctly different with regard to
patterns of key risk factors, including
range of exposures, prevalence of
exposures, correlations between
exposures, and variation in gene regions
of particular interest. It will also
improve the ability to understand the
causes of certain types of rare
lymphoma tumors in the United States
that occur at much higher rates in Asia.
As such, AsiaLymph will confirm and
extend previous findings and yield
novel insights into the causes of
lymphoma and leukemia in both Asia
and in the United States. The major
postulated risk factors for evaluation in
this study are chemical exposures (i.e.,
organochlorines, trichloroethylene, and
benzene) and genetic susceptibility.
Other factors potentially related to
lymphoma, such as viral infections,

E:\FR\FM\29OCN1.SGM

29OCN1

66549

Federal Register / Vol. 80, No. 209 / Thursday, October 29, 2015 / Notices
ultraviolet radiation exposure, medical
conditions, and other lifestyle factors
will also be studied. Patients from 11
participating hospitals will be screened
and enrolled. There will be a one-time
computer-administered interview, and

patients will also be asked to provide a
one-time blood and buccal cell mouth
wash sample and cases with lymphoma
or leukemia will be asked to make
available a portion of their pathology
sample.

OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
3,262.
Estimated Annualized Burden Hours

TABLE A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS
Instrument

Potential Study Subjects ...................
Eligible Potential Study Subjects ......
Consented Patient Cases .................

Screening Questions ........................
Consent Form ..................................
Core Questionnaire & Occupational
Job Module.
Core Questionnaire & Occupational
Job Module.
Pathology sample request and
tracking form.
Tracking forms .................................

Consented Patient Controls ..............
Study Pathologists ............................
Interviewers .......................................

Dated: October 16, 2015.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Opportunity for Public
Comment on the Dietary Supplement
Label Database
The Office of Dietary
Supplements (ODS) at the National
Institutes of Health, in partnership with
the National Library of Medicine (NLM),
has developed a Dietary Supplement
Label Database (DSLD) that is compiling
all information from the labels of dietary
supplements marketed in the United
States. ODS welcomes comments about
features to add and functionality
improvements to make so the DSLD may
become a more useful tool to users.
A federal stakeholder panel for the
DSLD will consider all comments
received. The ODS requests input from
academic researchers, government
agencies, the dietary supplement
industry, and other interested parties,
including consumers. The DSLD can be
accessed online at http://
dsld.nlm.nih.gov.

SUMMARY:

To ensure full consideration, all
comments must be received by 11:59
p.m. EST, November 27, 2015.

DATES:

Interested individuals and
organizations should submit their
responses to [email protected].

ADDRESSES:

VerDate Sep<11>2014

23:37 Oct 28, 2015

Jkt 238001

PO 00000

Frm 00062

Fmt 4703

Sfmt 4703

Annual
burden
hours

5/60
5/60
105/60

176
150
1,692

300

1

105/60

525

10

97

5/60

81

15

85

30/60

638

The DSLD
is a free resource that captures all
information present on dietary
supplement labels as provided by the
seller, including contents, ingredient
amounts, and any health-related
product statements, claims, and
cautions. It also provides a
downloadable photo of each label. Users
can search for and organize this
information in various ways. Research
scientists, for example, could use the
DSLD to determine total nutrient intakes
from food and supplements in
populations they study. Health care
providers can learn the content of
products their patients are taking.
Consumers might use the DSLD to
search for and compare products of
interest.
The DSLD currently contains 50,000
labels, and it is expected to grow rapidly
over the next three years to include
most of the estimated 75,000+ dietary
supplement products sold to American
consumers. The DSLD is updated
regularly to include any formulation
changes and label information in a
product. It also includes the labels of
products that have been discontinued
and are no longer sold. More
information about the DSLD and its
current capabilities is available at

SUPPLEMENTARY INFORMATION:

Time
per response
(hours)

1
1
1

Richard Bailen MBA, MHA., Office of
Dietary Supplements, National
Institutes of Health, 6100 Executive
Boulevard, Room 3B01, Bethesda, MD
20892–7517, Phone: 301–435–2920,
Fax: 301–480–1845, Email:
[email protected].

BILLING CODE 4140–01–P

Frequency of
response

2,110
1,801
967

FOR FURTHER INFORMATION CONTACT:

[FR Doc. 2015–27586 Filed 10–28–15; 8:45 am]

asabaliauskas on DSK5VPTVN1PROD with NOTICES

Number of
respondents

Types of respondents

http://www.dsld.nlm.nih.gov and at
Dwyer et al., 2014.1
ODS would like would like to receive
ideas and suggestions for how the DSLD
might evolve. What features might be
added, improved, or enhanced—for
example, in capabilities related to
search, sorting, organization, and
downloading of information—that
would make it a more valuable tool for
users?
Dated: October 23, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015–27625 Filed 10–28–15; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
1 Dwyer JT, Saldanha LG, Bailen RA, et al. A free
new dietary supplement label database for
registered dietitian nutritionists. J Acad Nutr Diet.
2014;114(10):1512–7.

E:\FR\FM\29OCN1.SGM

29OCN1